| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -16.99M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, OVID returned +171.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +71.8% |
| 1 year | +171.8% |
| 5 years | -20.7% |
| All-time high | $12.75 (May 2017) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in OVID would be worth today ›No. Ovid Therapeutics Inc. has not paid a dividend in the past 12 months.
Ovid Therapeutics Inc. stock trades on NASDAQ under the ticker symbol OVID.
Ovid Therapeutics Inc. is part of the Healthcare sector.
Ovid Therapeutics Inc. has a market cap of 546.83M USD, based on the latest quote.
Ovid Therapeutics Inc. is expected to report earnings around Nov 11, 2026. That date is an estimate and has not been confirmed by the company.
